2023 - Research.com Microbiology in France Leader Award
2022 - Research.com Microbiology in France Leader Award
His primary areas of study are Internal medicine, Immunology, Mycosis, Surgery and Transplantation. His Internal medicine research includes elements of Gastroenterology and Amphotericin B, Voriconazole, Caspofungin. His Immunology research is multidisciplinary, incorporating elements of Epidemiology and Incidence.
His Mycosis research includes themes of Fluconazole, Intensive care, Intensive care medicine, Disease and Immune reconstitution inflammatory syndrome. His Surgery study integrates concerns from other disciplines, such as Diabetes mellitus and Cancer. Olivier Lortholary has researched Transplantation in several fields, including Immunosuppression, Aspergillosis and Zygomycosis.
His main research concerns Immunology, Internal medicine, Surgery, Cryptococcosis and Intensive care medicine. The Immunology study combines topics in areas such as Immune reconstitution inflammatory syndrome, Acquired immunodeficiency syndrome and Disease. The various areas that Olivier Lortholary examines in his Internal medicine study include Gastroenterology and Aspergillosis.
Olivier Lortholary works in the field of Surgery, namely Mucormycosis. His research integrates issues of Flucytosine, Amphotericin B, Fluconazole, Cryptococcus neoformans and Mycosis in his study of Cryptococcosis. His research investigates the link between Intensive care medicine and topics such as Epidemiology that cross with problems in Incidence.
Olivier Lortholary mostly deals with Internal medicine, Aspergillosis, Intensive care medicine, Immunology and Fluconazole. He has included themes like Meningitis and Gastroenterology in his Internal medicine study. Olivier Lortholary combines subjects such as Mucormycosis, Clinical trial and Cryptococcosis with his study of Intensive care medicine.
His research in Immunology intersects with topics in Immune reconstitution inflammatory syndrome, Acquired immunodeficiency syndrome and Aspergillus. His Fluconazole research is multidisciplinary, relying on both Amphotericin B, Fungemia and Intensive care. His Transplantation research integrates issues from Disease, Posaconazole and Terbinafine.
His primary areas of investigation include Internal medicine, Prospective cohort study, Intensive care medicine, Fluconazole and Aspergillosis. His Internal medicine research is multidisciplinary, incorporating perspectives in Opportunistic infection and Echinocandin. His work deals with themes such as Mucormycosis and Computed tomography, which intersect with Intensive care medicine.
His studies deal with areas such as Meningitis, Incidence, Antiretroviral naive, Young adult and Meta-analysis as well as Fluconazole. His Aspergillosis study combines topics in areas such as Voriconazole and Caspofungin. His study looks at the relationship between Caspofungin and fields such as Drug, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman.
Clinical Infectious Diseases (2010)
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Loïc Guillevin;François Lhote;Martine Gayraud;Pascal Cohen.
Epidemiology and Clinical Manifestations of Mucormycosis
George Petrikkos;Anna Skiada;Olivier Lortholary;Emmanuel Roilides.
Clinical Infectious Diseases (2012)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi.
Clinical Infectious Diseases (2007)
Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark.
Clinical Infectious Diseases (2007)
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Olivier Leroy;Jean-Pierre Gangneux;Philippe Montravers;Jean-Paul Mira.
Critical Care Medicine (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: